Hca Healthcare, INC Form 4 insider transactions

HCA Healthcare's EVP and CFO, Mike A. Marks, was granted 11,945 stock appreciation rights with an exercise price of $482.53, vesting over four years.

HCA Healthcare CEO Samuel N. Hazen reported the exercise of stock appreciation rights, acquisition of common stock, and subsequent sale for tax obligations, alongside a new grant of stock appreciation rights.

HCA Healthcare's EVP and COO, Jon M. Foster, was granted 11,945 stock appreciation rights with a strike price of $482.53, vesting over four years.

HCA Healthcare's EVP and Chief Clinical Officer, Michael S. Cuffe, was granted 8,067 Stock Appreciation Rights with a strike price of $482.53.

HCA Healthcare's SVP & Chief Human Resources Officer, Jennifer Berres, was granted 6,206 Stock Appreciation Rights.

HCA Healthcare CEO Samuel N. Hazen reported gifting 14,830 shares of common stock on November 14, 2025, under a Rule 10b5-1 plan.

HCA Healthcare's EVP & Chief Legal & Administrative Officer, Michael R. McAlevey, exercised stock appreciation rights and subsequently sold a portion of his common stock holdings.

HCA Healthcare's EVP and CFO, Mike A. Marks, reported gift transactions involving common stock to family trusts and a direct gift acquisition and disposition.

HCA Healthcare CEO Samuel N. Hazen reported the exercise of stock appreciation rights and subsequent sale of common stock under a pre-arranged 10b5-1 plan.

HCA Healthcare's EVP and Chief Clinical Officer, Michael S. Cuffe, exercised stock appreciation rights and sold common stock shares as part of a pre-arranged 10b5-1 trading plan.

HCA Healthcare Director John Chidsey reported the acquisition of 496 restricted share units as part of an annual equity award, aligning his interests with shareholders.

CEO Samuel Hazen reports a transaction involving HCA Healthcare common stock, including acquisitions and disposals through various trusts.

Jon M. Foster, EVP and COO of HCA Healthcare, reports multiple transactions involving common stock, including sales, gifts, and transfers to trusts, affecting both direct and indirect ownership.

Mike Marks, EVP and CFO of HCA Healthcare, reports changes in beneficial ownership of company stock due to trust transfers, with no net change in total ownership.

Director William R. Frist reports changes in beneficial ownership of HCA Healthcare stock, including acquisitions, disposals, and indirect holdings through various entities.

Thomas F. Frist III, a director at HCA Healthcare, reported changes in his beneficial ownership of the company's common stock, including acquisitions of restricted share units and indirect holdings through various entities.

Director Andrea B. Smith reports the acquisition of common stock related to restricted share units and holdings in managed accounts.

Director Wayne Joseph Riley acquired 645 shares of HCA Healthcare common stock through an annual director equity award.

Director Michael Michelson reports acquisition and disposal of HCA Healthcare common stock and restricted share units.

Director Hugh F. Johnston reports acquiring and disposing of HCA Healthcare common stock, including restricted share units, as per a recent SEC Form 4 filing.

Director Nancy Ann Deparle reports acquisition of 645 shares of HCA Healthcare common stock related to restricted share units.

Director Robert J. Dennis reports acquisition of HCA Healthcare common stock and restricted share units, adjusting his beneficial ownership.

Bank of America Corp, Merrill Lynch, and Bank of America, N.A. jointly report changes in their beneficial ownership of HCA Healthcare, Inc. common stock through a series of acquisitions and disposals.

Christopher F. Wyatt, SVP & Controller of HCA Healthcare, reports acquisition and disposal of company stock.

SVP & Chief Nurse Executive Sammie S. Mosier reports acquisition and disposal of HCA Healthcare common stock and vesting of performance share units.

EVP & Chief Legal & Admin Off. Michael McAlevey reports acquisition and disposal of HCA Healthcare stock, including vesting of performance share units and transactions in managed accounts.

Mike Marks, EVP and CFO of HCA Healthcare, reports transactions involving common stock, including the vesting of performance share units.

HCA Healthcare CEO Samuel Hazen reports acquisition and disposal of company stock on February 13, 2025, according to a Form 4 filing.

Jon M. Foster, EVP and COO of HCA Healthcare, reports acquisition and disposal of common stock, including vesting of performance share units.

EVP and Chief Clinical Officer of HCA Healthcare, Michael S. Cuffe, reports acquisition and disposal of company stock.